Schedule 13G ownership disclosure

Relay Therapeutics Inc

Common Stock · CUSIP: 75943R102

Event date: 2025-06-30

Filing-level shares
9,379,851
Percent of class
5.47%
  • The Vanguard Group

    Shares: 9,379,851 · Class: 5.47%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000992
Form type
SCHEDULE 13G/A
Filer
Relay Therapeutics, Inc.
CIK
CIK 1812364
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub